MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02010nam a22002537a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20241112155349.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
241112b |||||||| |||| 00| 0 hin d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780128095522 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
NISER LIBRARY |
| Language of cataloging |
eng |
| Transcribing agency |
NISER LIBRARY |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616-006 |
| Item number |
SAL-E |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Epigenetic mechanisms in cancer |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
London : |
| Name of publisher, distributor, etc. |
Academic Press, |
| Date of publication, distribution, etc. |
2018 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xii, 380 pages : |
| Other physical details |
illustrations (chiefly color) ; |
| 490 ## - SERIES STATEMENT |
|---|
| Series statement |
Translational epigenetics series ; |
| Volume/sequential designation |
volume 3 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references at the end of each chapters and index. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Epigenetic Mechanisms in Cancer provides a comprehensive analysis of epigenetic signatures that govern disease development, progression and metastasis. Epigenetic signatures dictating tumor etiologies present an opportunity for biomarker identification which has broad potential for improving diagnosis, prognosis, prediction, and risk assessment. This volumes offers a unique evaluation of signature differences in childhood, sex-specific and race-specific cancers, and in doing so broadly illuminates the scope of epigenetic biomarkers in clinical environments. Chapters detail the major epigenetic process in humans consisting of DNA methylation, histone modifications and microRNAs (miRNAs) involved in the initiation, progression and metastasis of tumors. Also delineated are recent technologies such as next generation sequencing that are used to identify epigenetic profiles (primarily methylation analysis) in samples (normal, benign and cancerous) and which are highly important to the analysis of epigenetic outcomes. |
| 521 ## - TARGET AUDIENCE NOTE |
|---|
| Target audience note |
Researchers, early clinicians and advanced students investigating cancer at the genetic level |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Cancer |
| General subdivision |
Genetic aspects. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Epigenesis, Genetic |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Saldanha, Sabita |
| Relator term |
ed. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Reviews |
| Uniform Resource Identifier |
<a href="https://www.goodreads.com/book/show/39117490-epigenetic-mechanisms-in-cancer?ref=nav_sb_ss_1_31#CommunityReviews">https://www.goodreads.com/book/show/39117490-epigenetic-mechanisms-in-cancer?ref=nav_sb_ss_1_31#CommunityReviews</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Universal Decimal Classification |
| Koha item type |
Book |
